Update date
30 Jun 2024
Shareable Research Card
GENETIC TECHNOLOGIES LTD Liabilities
This metric view shows GENETIC TECHNOLOGIES LTD liabilities history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q2 2024
- Latest reported value
- A$4,356,106
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2024
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q2 2024.
- Latest reported value on this page: A$4,356,106.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Liabilities
Latest reported liabilities: A$4,356,106. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q2 2024
SEC-backed company facts were refreshed from filings filed on 30 Sep 2024.
Benchmark Context
How Liabilities compares with peers
GENETIC TECHNOLOGIES LTD sits in the bottom quarter of the current liabilities sample.
Compared with
Compared with 18 companies reporting liabilities in AUD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.3x the current sample midpoint. Liabilities is up about 18% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2022 to 30 Jun 2025.
- Nearby companies in this sample: Mobilicom Ltd and ALTERITY THERAPEUTICS LTD.
- Current sample position: rank #14 of 18 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
GENETIC TECHNOLOGIES LTD: Liabilities
Latest period: Q2 2024. Period end: 30 Jun 2024. Units: AUD and USD. Frequency: quarterly.
Liabilities is reported in company XBRL facts filed with the SEC.
Metric snapshot
- Latest value
- A$4,356,106
- Coverage range
- 30 Jun 2021 - 30 Jun 2024
- Fact rows
- 8
What this metric tells you
- Shows reported liabilities over 30 Jun 2021 - 30 Jun 2024.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 8 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
- View financial facts overview
- GENETIC TECHNOLOGIES LTD SEC filings
- Latest 10-Q/10-K hub
- Open SEC company facts
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare This Metric Across Companies
Compare latest available Liabilities levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
GENETIC TECHNOLOGIES LTD appears at rank #14 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | WESTPAC BANKING CORP (webnf) | A$1,005,492,000,000 | Instant - 30 Sep 2024 | Open WESTPAC BANKING CORP Liabilities |
| 2 | Telix Pharmaceuticals Ltd (tlx) | A$948,218,000 | Instant - 31 Dec 2024 | Open Telix Pharmaceuticals Ltd Liabilities |
| 3 | Carbon Revolution Public Ltd Co | A$251,862,000 | Instant - 30 Jun 2024 | Open Carbon Revolution Public Ltd Co Liabilities |
| 4 | Elevra Lithium Ltd (elvr) | A$177,268,000 | Instant - 30 Jun 2025 | Open Elevra Lithium Ltd Liabilities |
| 5 | NOVONIX Ltd (nvx) | A$75,218,083 | Instant - 30 Jun 2022 | Open NOVONIX Ltd Liabilities |
| 6 | KAZIA THERAPEUTICS LTD (kzia) | A$31,602,000 | Instant - 30 Jun 2024 | Open KAZIA THERAPEUTICS LTD Liabilities |
Metric Details
- Metric
- Liabilities (Liabilities)
- Frequency coverage
-
quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- ifrs-full
- Units tracked
- AUD and USD
- History range
-
30 Jun 2021 - 30 Jun 2024
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
8
Source: SEC company facts API
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Liabilities, Quarterly (AUD)
Liabilities, YoY Quarterly Change (%)
Liabilities, Quarterly (USD)
GENETIC TECHNOLOGIES LTD Quarterly Liabilities (AUD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | A$4,356,106 | +A$662,445 | +18% | 30 Jun 2024 | 20-F | 30 Sep 2024 | 2024 | FY |
| Q4 2023 | A$3,654,727 | -A$1,011,251 | -22% | 31 Dec 2023 | 6-K | 26 Feb 2024 | ||
| Q2 2023 | A$3,693,661 | -A$676,966 | -15% | 30 Jun 2023 | 20-F | 30 Sep 2024 | 2024 | FY |
| Q4 2022 | A$4,665,978 | 31 Dec 2022 | 6-K | 27 Feb 2023 | 2023 | Q2 | ||
| Q2 2022 | A$4,370,627 | +A$2,931,974 | +204% | 30 Jun 2022 | 20-F | 30 Sep 2024 | 2024 | FY |
| Q2 2021 | A$1,438,653 | -A$201,719 | -12% | 30 Jun 2021 | 20-F | 30 Aug 2023 | 2023 | FY |
GENETIC TECHNOLOGIES LTD Quarterly Liabilities (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2021 | $3,091,259 | 31 Dec 2021 | 6-K | 24 Feb 2022 | 2022 | Q2 | ||
| Q2 2021 | $1,438,653 | 30 Jun 2021 | 6-K | 24 Feb 2022 | 2022 | Q2 |
* marks a reported value that did not pass the local value check.